A detailed history of Headlands Technologies LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Headlands Technologies LLC holds 26,110 shares of AZN stock, worth $2.01 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
26,110
Previous 31,002 15.78%
Holding current value
$2.01 Million
Previous $2.09 Million 15.29%
% of portfolio
0.44%
Previous 0.63%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$61.03 - $69.57 $298,558 - $340,336
-4,892 Reduced 15.78%
26,110 $1.77 Million
Q4 2023

Feb 02, 2024

BUY
$61.89 - $69.28 $1.74 Million - $1.95 Million
28,094 Added 966.09%
31,002 $2.09 Million
Q3 2023

Nov 09, 2023

SELL
$64.85 - $71.7 $756,215 - $836,093
-11,661 Reduced 80.04%
2,908 $196,000
Q2 2023

Aug 03, 2023

BUY
$69.91 - $75.81 $1.02 Million - $1.1 Million
14,569 New
14,569 $1.04 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $393,293 - $511,042
7,255 New
7,255 $492,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $238B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.